• Latest Posts
In Depth 26 Oct 2023

Behind closed doors: The unseen controversies and scandals in Alzheimer’s drug trials

FDA approves Alzheimer’s treatment

Talking about Alzheimer’s disease: current drugs, clinical trials, and the pipeline

EMA accepts Marketing Authorization Application for lecanemab to treat early Alzheimer’s disease

Japanese companies look to reduce environmental impact

‘Best hope yet’ as results from Alzheimer’s drug trial reveal huge step forward

More News! 29 Sep 2022

Positive results from Eisai and Biogen Alzheimer’s trial